Our data offer valuable insights into the tumor secreted protein, IFI35, which enhances the proliferation and cytotoxicity of CD8+ T cells by activating the PI3K/AKT/mTOR signaling pathway and suppresses tumor growth in a CD8+ T cell-dependent manner. The gene discussed is AKT1; the disease is neoplasm.